Correlation Between Viking Therapeutics and Tango Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Tango Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Tango Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Tango Therapeutics, you can compare the effects of market volatilities on Viking Therapeutics and Tango Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Tango Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Tango Therapeutics.
Diversification Opportunities for Viking Therapeutics and Tango Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viking and Tango is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Tango Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tango Therapeutics and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Tango Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tango Therapeutics has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Tango Therapeutics go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Tango Therapeutics
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 1.11 times more return on investment than Tango Therapeutics. However, Viking Therapeutics is 1.11 times more volatile than Tango Therapeutics. It trades about -0.19 of its potential returns per unit of risk. Tango Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 5,259 in Viking Therapeutics on September 23, 2024 and sell it today you would lose (1,034) from holding Viking Therapeutics or give up 19.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Viking Therapeutics vs. Tango Therapeutics
Performance |
Timeline |
Viking Therapeutics |
Tango Therapeutics |
Viking Therapeutics and Tango Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viking Therapeutics and Tango Therapeutics
The main advantage of trading using opposite Viking Therapeutics and Tango Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Tango Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tango Therapeutics will offset losses from the drop in Tango Therapeutics' long position.Viking Therapeutics vs. Fate Therapeutics | Viking Therapeutics vs. Sana Biotechnology | Viking Therapeutics vs. Caribou Biosciences | Viking Therapeutics vs. Arcus Biosciences |
Tango Therapeutics vs. Third Harmonic Bio | Tango Therapeutics vs. Cullinan Oncology LLC | Tango Therapeutics vs. Edgewise Therapeutics | Tango Therapeutics vs. Rallybio Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
CEOs Directory Screen CEOs from public companies around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |